None listed
Conditions
Brief summary
The primary purpose of the study is to determine whether the addition of an autologous blood injection as an adjuvant therapy provides added benefit on top of the standard Alfredson's eccentric exercise regime alone for those with mid portion Achilles tendinopathy.
Interventions
Autologous Blood Injection. 3ml of blood will be drawn from either antecubital fossa with sterile no touch technique. No local anasthetic will be used. The blood will then be injected with a sterile no touch technique around the area of maximal Achilles tendon tenderness. It will not be injected directly into the tendon. There will not be dry needling and it will not be done under ultrasound guidance. We would hope that the time between aspiration and reinjection to be under one minute. All participants will have one injection, carried out two times in total, a month apart. All participants will carry out the standard Alfredson's eccentric exercise regime.
Sponsors
Study design
Eligibility
Inclusion criteria
Inclusion criteria: patients presenting to sports medicine/physiotherapy/ general practice clinics with first presentation of mid portion Achilles tendinopathy of at least 3 months duration
Exclusion criteria
Exclusion criteria: Bilateral Achilles tendinopathy, significant coagulopathy predisposing to bleeding, previous adjuvant treatment of the Achilles tendinopathy.